Health
Odyssey Therapeutics Climbs 11% After $304 Million US IPO
Odyssey Therapeutics Inc. signage during the company's IPO at the Nasdaq MarketSite in New York.
Photographer: Michael Nagle/BloombergOdyssey Therapeutics Inc. shares jumped 11% in its trading debut, after the biopharmaceutical company raised $304 million in an upsized US initial public offering and private placement.
The Boston-based company’s shares opened at $20 each on Friday in New York, above its IPO price of $18 apiece. The IPO ended significantly oversubscribed, people familiar with the matter said earlier.